Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

New Therapeutic Areas Ignite Investor Interest Amid Pandemic Reset

Jun 07 2023

• By Jessica Merrill

Business development idea and developing industry success through creative invention as a light bulb evolving to a gear shape as a 3D illustration.

Related Content

Pfizer Pays $43bn For Seagen With Goal Of Rapidly, Globally Advancing ADCs

Mar 13 2023

GSK’s Arexvy Is First RSV Vaccine Approved By FDA, But A Second Is Poised To Follow

May 03 2023

Lilly’s Donanemab Slows Cognitive Decline; FDA Filing Imminent

May 03 2023

Wegovy Demand Busts Through Novo Nordisk’s Expanded Capacity

May 04 2023

Pfizer Anticipates A 'Bolus Of Revenue' From RSV, Prevnar 20 Launches This Year

May 02 2023

Lilly’s Mounjaro Shows Strong Sales And Data As Firm Eyes Obesity Market

Apr 27 2023

AbbVie Gets Humira Erosion Right, But Skyrizi/Rinvoq Disappoint Investors

Apr 27 2023

Vaccines Helped GSK Post Strong Q1 Results Ahead Of RSV Approval

Apr 26 2023

Roche’s Vabysmo Grabs Top Growth Spot As Sales Decline

Apr 26 2023

J&J Hedges On 2025 Pharma Revenue Outlook

Apr 18 2023

Eisai/Biogen’s Leqembi Gets Some Medicare Coverage Certainty In CMS Update

Jun 01 2023

Related Companies

Novo Nordisk A/S

Eli Lilly and Company

Eisai Co., Ltd.

Biogen, Inc.

Roche Holding AG

Novartis AG

Bristol Myers Squibb Company

Johnson & Johnson

Additional Topics

Sales & Earnings Business Strategies Commercial Growth Strategy BioPharmaceutical Infectious Diseases Metabolic Disorders Neurology

More from Business Strategy

More from In Vivo

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window